The effect of tanshinone iia on the cardiovascular system in ovine fetus in Utero

American Journal of Chinese Medicine

Volumn 37, Issue 6, 2009, Pages 1031-1044

  Mao, Caiping ^a   Zhang, Yifan ^b   Zhang, Yuying ^a   Cao, Li ^a   Shao, Huan ^c   Wang, Liping ^c   Zhu, Liyan ^a   Xu, Zhice ^a,d  

^a SOOCHOW UNIVERSITY   (China)

^b SUZHOU MUNICIPAL HOSPITAL   (China)

^c WUXI NO 2 PEOPLE S HOSPITAL   (China)

^d LOMA LINDA UNIVERSITY   (United States)

Author keywords

Cardiovascular; Fetus; Pregnancy; Tanshinone IIA

Indexed keywords

CHLORIDE; GLUCOSE; HEART ENZYME; HEMOGLOBIN; LACTIC ACID; POTASSIUM; SODIUM; SODIUM CHLORIDE; TANSHINONE IIA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; CARBON DIOXIDE TENSION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CHLORIDE BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME ANALYSIS; EWE; FEMALE; FETUS; FETUS BLOOD; FETUS DEVELOPMENT; FETUS HEART; GLUCOSE BLOOD LEVEL; HEART FUNCTION TEST; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; LACTATE BLOOD LEVEL; LOW DRUG DOSE; MATERNAL BLOOD; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SATURATION; OXYGEN TENSION; POTASSIUM BLOOD LEVEL; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; DRUGS, CHINESE HERBAL; FEMALE; FETAL HEART; FETUS; HEMATOLOGY; MODELS, ANIMAL; MYOCARDIUM; OXYGEN; PHENANTHRENES; PREGNANCY; PREGNANCY TRIMESTER, THIRD; SALVIA MILTIORRHIZA; SHEEP; UTERUS;

EID: 76449108222     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X09007478     Document Type: Article

References (29)

1. Bensky, D., A. Gamble and T. Kaptchuk. Chinese herbal medicine. In: Materia Medica, 2nd ed. East, Seattle, WA, 1993, pp. 267-268.
2. Eric, J., P.Gurmit and G. Christine, Blood biochemistry and endocrinology in the human fetus between 11 and 17 weeks of gestation. Reprod. Biol. Med. 10: 38-44, 2000.
3. Huang, Y.T., T.Y. Lee, H.C. Lin, T.Y. Chou, Y.Y. Yang and C.Y. Hong. Hemodynamic effects of Salvia miltiorrhiza on cirrhotic rats. Can. J. Physiol. Pharm. 79: 566-572, 2001.
4. Ji, X.Y., B.K. Tan and Y.Z. Zhu. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol. Sin. 21: 1089-1094, 2000.
5. Kang, D.G., Y.G. Yun, J.H. Ryoo and H.S. Lee. Anti-hypertensive effect of water extract of danshen on renovascular hypertension through inhibition of the renin angiotensin system. Am. J. Chin. Med. 30: 87-93, 2002.
6. Kim, D.D., F.A. Sánchez, R.G. Durán, T. Kanetaka andW.N. Durán. Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am. J. Physiol. Heart Circ. 292: 2131-2137, 2007.
7. Ladenson, J.H. A personal history of markers of myocyte injury myocardial infarction. Clin. Chim. Acta 381: 3-8, 2007.
8. Lam, B.Y., A.C. Lo, X. Sun, H.W. Luo, S.K. Chung and N.J. Sucher. Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine 10: 286-291, 2003.
9. Lei, X.L. and G.C.Y. Chiou. Studies on cardiovascular actions of Salvia miltiorrhiza. Am. J. Chin. Med. 14: 26-32, 1986.
10. Li, X., Y. Zhuang and C. Chang. Effect of Salvia miltiorrhiza injection on umbilical artery hemodynamics during fetal distress in ewe. Chin. J. Integr. Tradit. West. Med. 18: 543-545, 1998.
11. Li, Y.L., Y.P. Zhang and P. Ceng. Analysis of allergic shock caused intrauterine fetal death induced by intravenous dripping of low molecular dextran and composita danshen injection to pregnant women. Mod. J. Integr. Chin. Tradit. West. Med. 23: 21, 2003.
12. Mao, C.P., J.X. Lv, H. Zhu, Y. Zhou, Y.Z. Chen, X. Feng and Z.C. Xu. Fetal functional capabilities in response to maternal hypertonicity associated with altered central and peripheral angiotensinogen mRNA in rats. Peptides 28: 1178-1184, 2007.
13. Niu, X.L., K. Ichimori, X. Yang, Y. Hirota, K. Hoshiai, M. Li and H. Nakazawa. Tanshinone II-A inhibits low density lipoprotein oxidation in vitro. Free Radic. Res. 33: 305-312, 2000.
14. Sze, F.K., F.F. Yeung, E. Wong and J. Lau. Does Danshen improve disability after acute ischemic stroke? Acta Neurol. Scand. 111: 118-125, 2005.
15. Takahashi, K., X. Ouyang, K. Komatsu, N. Nakamura, M. Hattori, A. Baba and J. Azuma. Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells. Biochem. Pharm. 64: 745-749, 2002.
16. Thorburn, G.D. and R. Harding. Textbook of Fetal Physiology. Oxford Medical Publications, New York, 1994.
17. Wu, P., J. Shi and R. Zou. Change of myocardial enzymes in patients with acute tetramine poisoning. Chin. J. Ind. Hyg. Occup. Dis. 24: 341-344, 2006.
18. Xia, W.J., M. Yang, T.F. Fok, K. Li, W.Y. Chan, P.C. Ng, H.K. Ng, K.W. Chik, C.C. Wang, G.J. Gu, K.S.Woo and K.P. Fung. Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage. Pediatr. Res. 58: 784-790, 2005.
19. Xiang, N.Z. and X.Y. Li. A observation on the effect of Guttae S. miltiorrhiza to alleviate angina in patients with CHD. Chin. J. Clin. Healthcare 7: 110-111, 2004.
20. Xu, Z.C. Fetal Physiology. Higher Education Press, 2007.
21. Xu, Z.C., G. Calvario, J.M. Yao, L. Day and M.G. Ross. Central angiotensin induction of fetal brain c-fos expression and swallowing activity. Am. J. Physiol. Reg. I. 280: 1837-1843, 2001a.
22. Xu,Z.C.,M.J.M. Nijland andM.G.Ross. Plasmaosmolality dipsogenic thresholds and c-fos expression in the near-term ovine fetus. Pediatric Res. 49: 678-685, 2001b.
23. Yang, G.R.. Salvia miltiorrhiza injection solution in therapy of cardiopulmonary disease: clinical analysis of 58 cases. Chin. Tradit. Herb. Drugs 35: 1039-1040, 2004.
24. Yu, G.R. Effect of Salvia miltiorrhiza on mesenteric microcirculatory blood flow in the dog measured by the Doppler effect of laser light. Chin. J. Integr. Tradit. West. Med. 4: 546-547, 1984.
25. Yusuf, S., P. Sleight, J. Pogue, J. Bosch, R. Davies and G. Dagenais. The heart outcomes prevention evaluation study investigators: Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. New Engl. J. Med. 342: 145-153, 2000.
26. Zhang,H., C.Yu, J.Y. Jia, S.W. Leung, Y.L. Siow, R.Y.Man and D.Y. Zhu. Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza). Acta Pharm. Sin. 23: 1163-1168, 2002.
27. Zhou, H. The effects of Danshen injection on umbilical artery blood flow of patients with intrahepatic cholestasis of pregnancy. Chin. J. Inform. Tradit. Chin. Med. 11: 195-196, 2004.
28. Zhou, L.M., Z. Zuo and M.S.S. Chow. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharm. 45: 1345-1359, 2005.
29. Zhou, Y.Q., C. Chang, X.T. Li, Y.L. Zhuang, G.X. Zhou and Y.M. Yang. A Doppler study of the umbilical blood flow of the experimental animal fetus with intrauterine distress. Chin. J. Ultra Med. 15: 89-90, 1999.